In a major healthcare shift, the UAE has approved Foundayo (orforglipron), a once-daily oral obesity pill developed by Eli Lilly. The decision by the Emirates Drug Establishment places the country among the first globally to introduce a needle-free alternative to injectable weight-loss treatments.This approval comes as obesity is increasingly linked to serious long-term conditions, including Type 2 diabetes, cardiovascular disease, and certain cancers. Foundayo’s convenience is what makes it stand out. Unlike injectable GLP-1 drugs, it is taken as a simple daily pill and does not require strict timing around meals or water intake, making adherence easier for patients.
UAE’s obesity pill offers needle-free weight loss
Despite the growing buzz, Foundayo is not meant for casual or cosmetic use. It will only be available through prescription and under strict medical supervision. Doctors across the UAE are expected to follow clear eligibility guidelines before recommending the drug.Patients typically qualify if they have a body mass index (BMI) of 30 or above, which falls under clinical obesity, or a BMI above 27 combined with related health conditions. These include metabolic and lifestyle diseases such as diabetes, hypertension, high cholesterol, sleep apnea, and joint stress conditions.Before starting treatment, patients will undergo detailed medical assessments. These include blood work, metabolic screening, and a full review of medical history. Specialists such as endocrinologists and internal medicine experts will play a central role in determining whether the medication is appropriate, ensuring its use remains targeted and medically justified.
How does the Foundayo weight loss pill work?
Foundayo belongs to a class of medications known as GLP-1 receptor agonists, which mimic natural hormones in the body that regulate appetite and blood sugar levels. In practical terms, the drug works by helping patients feel full earlier, reducing hunger signals, and lowering overall calorie intake without forcing drastic dietary restrictions.Clinical trials have shown strong and consistent results. Patients on higher doses recorded an average weight loss of up to 12.4 percent, while some studies reported reductions of around 12 kilograms over a 72-week period. Beyond weight loss, early findings also suggest improvements in cholesterol levels, blood pressure, and markers linked to heart disease risk, pointing to broader metabolic benefits.At the same time, doctors caution that side effects are possible, particularly during the early stages of treatment. Some patients reported nausea, mild digestive discomfort, and gastrointestinal issues, especially when dosage levels were increased. These effects were generally manageable but highlight the importance of medical supervision throughout the treatment process.
When will it be available in the UAE?
The pill is expected to be available across UAE pharmacies starting May 2026, but access will remain controlled through prescription channels. Health experts are clear that Foundayo is not a shortcut or a one-time fix. Instead, it is designed as part of a long-term treatment plan.In many cases, patients may need to stay on the medication for extended periods, sometimes lifelong, depending on their condition. Doctors emphasize that stopping the drug without maintaining lifestyle changes such as a balanced diet and regular exercise could result in weight regain. The medication works best when combined with sustained behavioral changes rather than replacing them.There are also clear medical exclusions. The drug is not recommended for pregnant or breastfeeding women, and it may not be suitable for individuals with certain thyroid cancers, endocrine disorders, or severe gastrointestinal and kidney conditions. These restrictions reinforce the need for careful screening before starting treatment.
Expected price of Foundayo in the UAE
While the official price of Foundayo in the UAE has not yet been confirmed, early estimates suggest it could be positioned within the same range as existing GLP-1 treatments. Injectable alternatives currently available in the UAE often cost anywhere between Dh800 and Dh1,500 per month, depending on dosage and brand.Industry experts expect Foundayo to be priced competitively within this bracket, though its oral format could influence final pricing depending on demand and insurance coverage. Another key factor will be whether UAE insurers classify the drug under essential obesity treatment or elective therapy, which could significantly affect patients’ out-of-pocket costs.Affordability is likely to play a crucial role in adoption. While the convenience of a daily pill is expected to attract strong demand, long-term use means that pricing and insurance support will ultimately determine the treatment’s accessibility.
UAE authorities stress safety checks
UAE regulators have made it clear that the approval of Foundayo is a controlled medical step, not a mass-market weight loss solution. The Emirates Drug Establishment said the drug was cleared only after a detailed scientific review of its safety, effectiveness and clinical trial performance, positioning it as part of the country’s broader strategy to tackle rising obesity rates.In its official statement, the authority emphasised that the move reflects the UAE’s commitment to bringing advanced treatments to patients while maintaining high regulatory standards. Dr Fatima Al Kaabi, the authority’s Director-General, noted that addressing obesity remains a national priority due to its link to over 200 diseases, including diabetes, hypertension and cancer. She added that the approval marks a shift toward more patient-friendly therapies.Medical experts have also flagged safety considerations linked to drugs in the GLP-1 receptor agonist class. Clinical data shows the treatment can cause mild-to-moderate gastrointestinal side effects such as nausea and vomiting, particularly in the early stages or at higher doses.Regulators further stress that the pill is not a standalone cure. It is designed for long-term use as part of a structured obesity management plan that includes lifestyle changes such as diet and physical activity. By combining strict prescription controls with ongoing monitoring, UAE authorities aim to ensure that innovation in treatment does not come at the cost of patient safety while expanding access to effective weight management solutions.[Note: The information provided in this article is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any new medication or treatment and before changing your diet or supplement regimen.]
